RAS-antagonist and beta-blocker up-to maximal dosages clinical trials

NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

This study looks at how high doses of certain heart medicines (RAS-antagonists and beta-blockers) might help prevent heart problems in people with Type 2 diabetes who haven't had heart disease before. It also checks a blood marker called NT-proBNP.